SEC Form 4 · accession 0000950157-17-000719
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas McGrane
Officer — Chief Financial Officer
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 6:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | May 19, 2017 | M | 47,508 | $3.84 | A | 79,592 | D | |
| Class A Common StockF1 | May 19, 2017 | S | 47,508 | $24.30 | D | 32,084 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Option (right to buy)F2 | $3.84 | May 19, 2017 | M | 47,508 | D | — | Apr 1, 2024 | Class A Common Stock | 47,508 | 222,952 | D |
Explanation of responses
- F1Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- F2The Class A Common Stock Options exercised vested on November 1, 2015.